Harry Petrushkin

908 total citations
49 papers, 421 citations indexed

About

Harry Petrushkin is a scholar working on Ophthalmology, Hematology and Rheumatology. According to data from OpenAlex, Harry Petrushkin has authored 49 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Ophthalmology, 11 papers in Hematology and 10 papers in Rheumatology. Recurrent topics in Harry Petrushkin's work include Ocular Diseases and Behçet’s Syndrome (31 papers), Retinal and Optic Conditions (16 papers) and Autoimmune and Inflammatory Disorders Research (11 papers). Harry Petrushkin is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (31 papers), Retinal and Optic Conditions (16 papers) and Autoimmune and Inflammatory Disorders Research (11 papers). Harry Petrushkin collaborates with scholars based in United Kingdom, United States and Spain. Harry Petrushkin's co-authors include Miles Stanford, Emilio Ovuga, Jed Boardman, Farida Fortune, Allon Barsam, Ameenat Lola Solebo, Catey Bunce, Stephen J. Tuft, Ali Jawad and B Foot and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Harry Petrushkin

44 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry Petrushkin United Kingdom 13 259 88 72 55 53 49 421
Lori Ponder United States 13 114 0.4× 25 0.3× 143 2.0× 23 0.4× 73 1.4× 28 417
Kathleen Stoessel United States 12 239 0.9× 90 1.0× 11 0.2× 75 1.4× 34 0.6× 16 572
Kayur H. Shah United States 8 264 1.0× 40 0.5× 25 0.3× 170 3.1× 19 0.4× 10 539
Charles Makin United States 10 49 0.2× 46 0.5× 86 1.2× 50 0.9× 49 0.9× 26 397
Catherine B. McGuiness United States 12 49 0.2× 33 0.4× 40 0.6× 78 1.4× 73 1.4× 33 484
D. Wilkin Parke United States 17 548 2.1× 358 4.1× 19 0.3× 90 1.6× 48 0.9× 38 753
Jemshed A. Khan United States 14 331 1.3× 95 1.1× 17 0.2× 76 1.4× 74 1.4× 40 634
Sébastien Duband France 10 58 0.2× 139 1.6× 9 0.1× 45 0.8× 47 0.9× 28 367
Seung Min Hahn South Korea 12 33 0.1× 33 0.4× 12 0.2× 44 0.8× 41 0.8× 52 408
Judith Barash Israel 16 66 0.3× 15 0.2× 180 2.5× 151 2.7× 124 2.3× 30 601

Countries citing papers authored by Harry Petrushkin

Since Specialization
Citations

This map shows the geographic impact of Harry Petrushkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Petrushkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Petrushkin more than expected).

Fields of papers citing papers by Harry Petrushkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Petrushkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Petrushkin. The network helps show where Harry Petrushkin may publish in the future.

Co-authorship network of co-authors of Harry Petrushkin

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Petrushkin. A scholar is included among the top collaborators of Harry Petrushkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Petrushkin. Harry Petrushkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wagner, Siegfried K., et al.. (2025). Endophthalmitis after Pars Plana Vitrectomy. Ophthalmology Retina. 9(9). 883–891. 1 indexed citations
3.
Acharya, Nisha R., Athimalaipet V Ramanan, Catherine Guly, et al.. (2025). Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial. The Lancet. 405(10475). 303–313. 3 indexed citations
4.
Solebo, Ameenat Lola, Eibhlin McLoone, Harry Petrushkin, et al.. (2025). Incidence, sociodemographic and presenting clinical features of childhood non-infectious uveitis: findings from the UK national inception cohort study. British Journal of Ophthalmology. 109(8). 955–961.
5.
Foeldvari, Ivan, Harry Petrushkin, Regitze Bangsgaard, et al.. (2024). A practical approach to uveitis screening in children with juvenile idiopathic arthritis. British Journal of Ophthalmology. 109(3). 372–376. 3 indexed citations
6.
Foeldvari, Ivan, Ameenat Lola Solebo, Joke H. de Boer, et al.. (2024). Proceedings of the 31st European Paediatric Rheumatology Congress: part 2. Pediatric Rheumatology. 22(S2). 83–83. 4 indexed citations
7.
Testi, Ilaria, Camilo Brandão‐de‐Resende, Alejandra de‐la‐Torre, et al.. (2023). Ocular Inflammatory Events Following COVID-19 Vaccination in the Paediatric Population: A Multinational Case Series. Ocular Immunology and Inflammation. 32(7). 1237–1242. 4 indexed citations
8.
Petrushkin, Harry, et al.. (2023). Quality assessment of anterior segment OCT images: Development and validation of quality criteria. Photodiagnosis and Photodynamic Therapy. 45. 103886–103886. 3 indexed citations
10.
Kon, Onn Min, Nicholas A. V. Beare, David Connell, et al.. (2022). BTS clinical statement for the diagnosis and management of ocular tuberculosis. BMJ Open Respiratory Research. 9(1). e001225–e001225. 17 indexed citations
11.
Karamchandani, Urvi, et al.. (2022). Long-term ocular and visual outcomes following symptomatic and asymptomatic congenital CMV infection: a systematic review protocol. BMJ Open. 12(5). e059038–e059038. 3 indexed citations
12.
Testi, Ilaria, et al.. (2022). Hypotony in uveitis: an overview of medical and surgical management. British Journal of Ophthalmology. 107(12). 1765–1770. 3 indexed citations
13.
Petrushkin, Harry, Andrew R. Webster, Elena Moraitis, et al.. (2021). A Novel Pathogenic NOD2 Variant in a Mother and Daughter with Blau Syndrome. Ophthalmic Genetics. 42(6). 753–764. 3 indexed citations
14.
Mansour, Hana A., Pınar Özdal, Sibel Kadayıfçılar, et al.. (2021). Familial Mediterranean fever associated frosted branch angiitis, retinal vasculitis and vascular occlusion. Eye. 36(11). 2157–2162. 5 indexed citations
15.
Solebo, Ameenat Lola, et al.. (2021). Long-Term Outcomes of Pediatric Idiopathic Intermediate Uveitis. American Journal of Ophthalmology. 237. 41–48. 9 indexed citations
16.
Taylor, Thomas R., Benjamin M. Jacobs, Gavin Giovannoni, Harry Petrushkin, & Ruth Dobson. (2020). Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study. Multiple Sclerosis and Related Disorders. 43. 102209–102209. 6 indexed citations
17.
Blacklock, B., et al.. (2020). Ocular Tuberculosis: More than ‘Of Mice and Men’. Ocular Immunology and Inflammation. 30(1). 34–38. 3 indexed citations
18.
Barsam, Allon, Harry Petrushkin, Wen Xing, et al.. (2016). Case-control study of risk factors for acute corneal hydrops in keratoconus. British Journal of Ophthalmology. 101(4). 499–502. 16 indexed citations
19.
Petrushkin, Harry, Mostafa Elgohary, & Paul Sullivan. (2015). RESCUE PNEUMATIC RETINOPEXY IN PATIENTS WITH FAILED PRIMARY RETINAL DETACHMENT SURGERY. Retina. 35(9). 1851–1859. 10 indexed citations
20.
Hughes, Edward, et al.. (2008). Tuberculous orbital apex syndromes. British Journal of Ophthalmology. 92(11). 1511–1517. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026